Clinical Trial Update: Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the safety and immunogenicity of a monovalent inactivated influenza A (H5N8) vaccine in adults and older adults is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avian Influenza

Drugs mentioned

• Monovalent influenza vaccine A (H5N8), inactivated, fragmented and adjuvanted (Influenza A(H5N8) vaccine, inactivated, fragmented, adjuvanted)

Snippet

Sponsor: Butantan Institute | Conditions: Avian Influenza A Virus | Phase 1, Phase 2 | Status: RECRUITING